Transfusion-related Acute Lung Injury: More Questions Than Answers?

(Accepted for publication March 16, 2015.) Center for Biologics Evaluation and Research, the putative cause of TRALI is anti–human leukocyte antigen or granulocyte antibodies in the donor blood product with 89% of TRALI cases having these antibodies.5 Clifford et al. did not present data on these antibodies, but the 2013 SHOT annual report suggested that antibodies were present in 40% of TRALI cases. Assuming the anti– human leukocyte antigen/granulocyte antibody mechanism is correct, it is important to explain why patients who receive only red cell transfusion appear to have a higher incidence of TRALI than those who receive only plasma. One possibility is that because red cell units are still collected from female donors and there is a small amount of plasma present in these units, they may presently carry a higher risk for TRALI. Alternatively, stored erythrocyte units may cause TRALI through a different mechanism that has not yet been elucidated. The study by Clifford et al. also suggested that increased volumes of transfused blood products were associated with TRALI, which demonstrates the blurred lines that exist between TRALI and transfusion-associated circulatory overload. In their study, Clifford et al. classified patients as having both diagnoses when neither diagnosis alone could fully explain the clinical picture. We believe there is considerable overlap between these two diagnoses, and this may account for the underreporting that occurs with TRALI to some degree. Recent alternatives to standard allogeneic plasma transfusion (e.g., prothrombin complex and solvent detergent plasma) potentially eliminate the risk for TRALI from plasma transfusion altogether, but to date, there are questions about their safety and high costs. These products are prepared through large-scale pooling, and thus, the causative antibodies for TRALI may be diluted to insignificant levels. Thus far, there have been no cases of TRALI reported with solvent detergent plasma or prothrombin complex, but there has been limited surveillance.6 In addition, the data from Clifford et al. and the SHOT annual reports suggest that Transfusion-related Acute Lung Injury: More Questions Than Answers?